200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 7057-48-9

7057-48-9

7057-48-9 | ((2S,5R)-5-(6-Amino-9H-purin-9-yl)-2,5-dihydrofuran-2-yl)methanol

CAS No: 7057-48-9 Catalog No: AG005HRC MDL No:MFCD00040965

Product Description

Catalog Number:
AG005HRC
Chemical Name:
((2S,5R)-5-(6-Amino-9H-purin-9-yl)-2,5-dihydrofuran-2-yl)methanol
CAS Number:
7057-48-9
Molecular Formula:
C10H11N5O2
Molecular Weight:
233.2266
MDL Number:
MFCD00040965
IUPAC Name:
[(2S,5R)-5-(6-aminopurin-9-yl)-2,5-dihydrofuran-2-yl]methanol
InChI:
InChI=1S/C10H11N5O2/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(3-16)17-7/h1-2,4-7,16H,3H2,(H2,11,12,13)/t6-,7+/m0/s1
InChI Key:
JFUOUIPRAAGUGF-NKWVEPMBSA-N
SMILES:
OC[C@@H]1C=C[C@@H](O1)n1cnc2c1ncnc2N
UNII:
SK35877HI5

Properties

Complexity:
313  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
233.091g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
233.231g/mol
Monoisotopic Mass:
233.091g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
99.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.4  

Literature

Title Journal
[Conformational capacity of 2',3'-didehydro-2',3'-dideoxyadenosine as a key to understanding its biological activity: results of quantum chemical modelling]. Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20110101
Synthesis and antiviral evaluation of thieno[3,4-d]pyrimidine C-nucleoside analogues of 2',3'-dideoxy- and 2',3'-dideoxy-2',3'-didehydro-adenosine and -inosine. Bioorganic & medicinal chemistry 20090315
Effects of two novel nucleoside analogues on different hepatitis B virus promoters. World journal of gastroenterology 20080328
Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells. World journal of gastroenterology 20080227
Inhibition of reverse transcriptase activity of hepatitis B virus polymerase by β-l-D4A-TP. Acta virologica 20080101
Effect and mechanism of beta-L-D4A on DNA polymerase alpha. World journal of gastroenterology 20071214
[Isosteric triphosphonate analogues of dNTP: synthesis and substrate properties toward various DNA polymerases]. Bioorganicheskaia khimiia 20070101
Synthesis and conformational analysis of new cyclobutane-fused nucleosides. Organic letters 20060202
[Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro]. Yao xue xue bao = Acta pharmaceutica Sinica 20050901
Synthesis, structure-activity relationships, and drug resistance of beta-d-3'-fluoro-2',3'-unsaturated nucleosides as anti-HIV Agents. Journal of medicinal chemistry 20040617
Inhibition of hepatitis B virus by a novel L-nucleoside, beta-L-D4A and related analogues. World journal of gastroenterology 20030815
[Inhibition of the replication of hepatitis B virus in vitro by a novel nucleoside analogue (beta-L-D4A)]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20030701
[Effect and mechanism of beta-L-D4A (a novel nucleoside analog) against hepatitis B virus]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 20030501
Synthesis and studies of 3'-C-trifluoromethyl nucleoside analogues bearing adenine or cytosine as the base. Bioorganic & medicinal chemistry 20021001
Stereoselective synthesis of a novel carbocyclic nucleoside. The Journal of organic chemistry 20011102
Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages. Antimicrobial agents and chemotherapy 20000101
cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system. Journal of medicinal chemistry 19990506
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus. FEBS letters 19970630
Potential prodrug derivatives of 2',3'-didehydro-2',3'-dideoxynucleosides. Preparations and antiviral activities. Journal of medicinal chemistry 19920724
Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides. Journal of medicinal chemistry 19890801
Comparative activity of 2',3'-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells. Biochemical pharmacology 19881001
Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside. Biochemical pharmacology 19880401
Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis. Journal of medicinal chemistry 19871101
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents. Journal of medicinal chemistry 19870801
The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides. Molecular pharmacology 19870701
The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Biochemical and biophysical research communications 19870529
Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro. Biochemical and biophysical research communications 19870115

Related Products

© 2019 Angene International Limited. All rights Reserved.